NCT01579968View on ClinicalTrials.gov

Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery

CompletedOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

March 10, 1999

Primary Completion Date

March 9, 2010

Study Completion Date

March 9, 2010

Conditions
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Interventions
DRUG

eptacog alfa (activated)

Safety and effectiveness data collection in connection with the use of eptacog alpha in daily clinical practice

Trial Locations (1)

1000005

Novo Nordisk Investigational Site, Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY